EZH2 and cancer: It has been reported that the genomic loss of miR-101 can result in the upregulation of EZH2 in prostate cancer36 and miR-101 promote apoptosis in cancer cells.12,37 EZH2 may also contribute to apoptosis resistance by linking the genomic loss of miR-101 to miR-31 silencing.